353 related articles for article (PubMed ID: 38225990)
21. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
22. Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease.
Tapia-Rojas C; Inestrosa NC
Neural Regen Res; 2018 Oct; 13(10):1705-1710. PubMed ID: 30136680
[TBL] [Abstract][Full Text] [Related]
23. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
[TBL] [Abstract][Full Text] [Related]
24. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
25. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
27. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
28. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
29. Focusing on the structure and the function of Pin1: new insights into the opposite effects of fever on cancers and Alzheimer's disease.
Wang JZ; Zhang YH; Sun XW; Li YL; Li SR; Zhang Y; Zhang T; Song GQ
Med Hypotheses; 2013 Aug; 81(2):282-4. PubMed ID: 23648381
[TBL] [Abstract][Full Text] [Related]
30. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
32. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
Yang Y; Zhang Z
Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's Disease and Cancer: When Two Monsters Cannot Be Together.
Majd S; Power J; Majd Z
Front Neurosci; 2019; 13():155. PubMed ID: 30881282
[TBL] [Abstract][Full Text] [Related]
34. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
[TBL] [Abstract][Full Text] [Related]
35. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
36. GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.
Sun Z; Sun L; Tu L
J Alzheimers Dis; 2020; 76(4):1513-1526. PubMed ID: 32651311
[TBL] [Abstract][Full Text] [Related]
37. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
39. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Markesbery WR; Zhou XZ; Lu KP; Butterfield DA
Neurobiol Aging; 2006 Jul; 27(7):918-25. PubMed ID: 15950321
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway.
Yi J; Chen B; Yao X; Lei Y; Ou F; Huang F
J Cell Biochem; 2019 Oct; 120(10):18053-18065. PubMed ID: 31190362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]